Caladrius
is a New Jersey-based biopharmaceutical company that develops and commercializes cell therapies for the regeneration of damaged tissues... Read moreCaladrius
is a New Jersey-based biopharmaceutical company that develops and commercializes cell therapies for the regeneration of damaged tissues... Read more
1980
PrivateMerged with Cend Therapeutics, Inc.
News
Mar 01, 2024
Owler
Caladrius Biosciences, Inc.: Caladrius's employee count changed from 27 in Dec 2022 to 25 in Dec 2023
Apr 04, 2023
Owler
Caladrius Biosciences, Inc.: Caladrius's employee count had no change from Dec 2021 to Dec 2022
Nov 07, 2022
MarketScreener
Caladrius: Lisata Therapeutics Announces Participation in Upcoming Conferences in November 2022
Oct 25, 2022
Seeking Alpha
Caladrius: Lisata Therapeutics (LSTA) presents at LD Micro Main Event XV - Slideshow
Sep 15, 2022
BioSpace
Caladrius: Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
Aug 05, 2022
MarketScreener
Caladrius: Caladrius Biosciences : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K
Aug 03, 2022
centralcharts
Press Release: Caladrius : CALADRIUS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Caladrius Biosciences, Inc. - CLBS
Aug 02, 2022
GlobeNewswire
Press Release: Caladrius : Caladrius Biosciences Completes Enrollment in Phase 1b Study of CLBS201 for the Treatment of Diabetic Kidney Disease
Jul 06, 2022
StreetInsider
Press Release: Caladrius : Cend Therapeutics Announces Publication of Pancreatic Cancer Trial Data in the Lancet Gastroenterology and Hepatology
Jun 09, 2022
GlobalNewswire
Press Release: Caladrius : Caladrius Biosciences Announces Merger Partner, Cend Therapeutics, has Treated First Patient in Phase 2b Trial of CEND-1 in Collaboration with Australasian Gastro-Intestinal Cancer Trials Group
Caladrius Competitors
1
2
3
4
5
6
7
8
9
10